The Effect of Music Therapy as an Adjuvant in the Vital Signs of the Neonate
1 other identifier
interventional
45
1 country
1
Brief Summary
The admission of a newborn to the neonatal intensive care unit (NICU) represents a potentially harmful sound environment coupled with multiple stressful events. However, a strategy such as music therapy (delivered by a trained music therapist) appears to be a non-invasive, safe, and cost-effective alternative that assists newborns in their physiological self-regulation with a beneficial effect on stabilizing neonatal vital signs, so it can be used as a complementary strategy to medical management. The aim of this study is to determine the effect of live and pre-recorded music therapy on vital sign variables in newborns older than 32 weeks hospitalized in the neonatal intensive care unit of a high-complexity health institution in Colombia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2024
CompletedStudy Start
First participant enrolled
May 3, 2024
CompletedFirst Posted
Study publicly available on registry
May 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2024
CompletedSeptember 19, 2024
September 1, 2024
3 months
April 26, 2024
September 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Heart rate
The measurement will be continuously quantified in terms of number of pulsations per minute continuously.
The baseline measurement will be taken before the intervention, and will continue for 30 minutes during the intervention and for a further 30 minutes after the intervention has been completed.
Secondary Outcomes (2)
Respiratory rate
The baseline measurement will be taken before the intervention, and will continue for 30 minutes during the intervention and for a further 30 minutes after the intervention has been completed.
Oxygen saturation
The baseline measurement will be taken before the intervention, and will continue for 30 minutes during the intervention and for a further 30 minutes after the intervention has been completed.
Study Arms (3)
Live music
EXPERIMENTALIt is performed by a music therapist using the guitar as the only musical instrument. Instrumental lullabies are used, selected by the patient's legal guardian.
Pre-recorded music
EXPERIMENTALPre-recorded music of the lullaby genre, instrumental type, using a speaker placed inside the patient's incubator.
Control
NO INTERVENTIONThere will be no musical intervention.
Interventions
Music therapy is a non-pharmacological therapeutic intervention that will be implemented through two modalities: live and pre-recorded instrumental lullabies music.The volume control will be conducted within the groups through the use of a decibel regulator, with a maximum volume of 70 dB. During the intervention and for a period of 30 minutes following its conclusion, singing will be prohibited by the music therapist or the parents. Both live and pre-recorded music will be instrumental in nature, lacking any lyrics.
Eligibility Criteria
You may qualify if:
- Newborns with gestational age at birth greater than or equal to 32 weeks.
- Birth weight greater than or equal to 1500 grams.
- Be at least 72 hours of postnatal age.
You may not qualify if:
- Respiratory disturbances in the last 48 hours such as: Apnea or Brief Resolved Unexplained Events (BRUE), need for invasive mechanical ventilation
- Hemodynamic alterations in the last 48 hours such as: Hypotension (systolic, diastolic, or mean BP \< P5) or hypertension (systolic, diastolic, or mean BP \> P95), bradycardia (HR \< 100/min), shock of any etiology, requirement for volume expanders, infusion of inotropics, vasodilators and/or prostaglandin E1.
- Neurological alterations such as: Perinatal asphyxia at birth manifested by the need for resuscitation, APGAR \< 3 at 5 minutes and/or ≤ 5 at 10 minutes, and metabolic acidosis in cord gases with a potential of hydrogen (pH) \< 7 and base excess (BE) \< -12, hypoxic-ischemic encephalopathy, seizure syndrome for up to 48 hours after the last clinical event or alteration of the brain pattern, interventricular hemorrhage in preterm infants in the first week of diagnosis.
- Management with Extracorporeal membrane oxygenation (ECMO) and/or nitric oxide
- Temperature less than 36.5 C or greater than 37.5 C.
- Patient under pharmacological sedation or use of beta-blockers.
- Congenital heart disease, operated on or not.
- Congenital malformations
- Surgical emergencies or recovery from a surgical procedure performed within the last 48 hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Claudia Aristizáballead
- Sanitas Universitycollaborator
Study Sites (1)
Clínica Universitaria Colombia
Bogotá, Colombia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Johana Benavides, MSc
Unisanitas
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
April 26, 2024
First Posted
May 9, 2024
Study Start
May 3, 2024
Primary Completion
July 18, 2024
Study Completion
July 18, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
When the study ends, individual participant data could be shared with the approval of the research ethics committee.